New Releases Category, PEPTIDE Nano Liposomals, Peptides
BPC-157 PEPTIDE NANO LIPOSOMAL LIQUID 30ML (1MG/ML, 30MG BOTTLE)
$119.99
BPC-157 nano liposomal is an oral nano particle peptide.
| CAS Number | 137525-51-0 |
| Other Names | BPC157, BPC 157, Bepecin, 8ED8NXK95P, PLD-116, PL-14736, Body protection compound 15 |
| IUPAC Name | (4S)-4-[(2-aminoacetyl)amino]-5-[(2S)-2-[(2S)-2-[(2S)-2-[[2-[[(2S)-6-amino-1-[(2S)-2-[[(2S)-1-[[(2S)-3-carboxy-1-[[(2S)-3-carboxy-1-[[(2S)-1-[[2-[[(2S)-1-[[(1S)-1-carboxy-2-methylpropyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxohexan-2-yl]amino]-2-oxoethyl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-5-oxopentanoic acid |
| Molecular Formula | C₆₂H₉₈N₁₆O₂₂ |
| Molecular Weight | 1419.5 |
| Purity | ≥99% Pure (LC-MS) |
| Material Safety Data Sheet (MSDS) | View Material Safety Data Sheet |
| Liquid Availability | 30mL nano liposomal liquid (1mg/mL, 30mg total)
15mL liquid spray solution (includes 5 milligrams of peptide vial) 15mL liquid spray solution (includes 10 milligrams of peptide vial) |
| Particle Size | 79.6nm |
| Powder Availability | 5 milligrams vial (lyophilized/freeze-dried)
10 milligrams vial (lyophilized/freeze-dried) 60 capsules (500mcg/capsule, 30mg (30,000mcg) total bottle) |
| Storage Condition | Shelf life of 8 months, store cold, keep refrigerated. Do NOT freeze. |
| Terms | All products are for laboratory developmental research USE ONLY. Products are not for human consumption. |
| Dimensions | 0.5 × 0.5 × 1 in |
|---|---|
| Options | 1 (10mg) Peptide Vial With Liquid Spray Solution, 1 (5mg) Peptide Vial With Liquid Spray Solution, 10 MILLIGRAMS VIAL, 30mg total bottle), 5 MILLIGRAMS VIAL, 60 capsules (500mcg/capsule, Peptide With Liquid Spray Solution |
Related products
-
New Releases Category
PALMITOYL TRIPEPTIDE-38 (MATRIXYL SYNTHE 6) PEPTIDE 200MG VIAL
$75.99 Add to cart
Reviews
There are no reviews yet.